Country Profile

Mozambique

Mozambique is a significant market for Indian pharmaceutical exports — $143M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 77% of shipments, with vaccines contributing $24.3M. The compound annual growth rate since FY2015 stands at 5.9%.

🇲🇿 $143M · 1.9× growth since FY2015 · 5.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$143M
Exports FY2025–26 DGCIS
1.9×
Growth FY2015→2026
5.9%
CAGR FY2015→2026
77%
Medicines Share
5
Product Categories Supplied
Mozambique is a significant market for Indian pharmaceutical exports — $143M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 77% of shipments, with vaccines contributing $24.3M. The compound annual growth rate since FY2015 stands at 5.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $111M (77.4%) Vaccines $24.3M (16.9%) Medicine Ingredients $6.38M (4.4%) Surgical & Hospital Supplies $1.37M (1.0%) Traditional & Herbal $349K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Mozambique in the RBI overseas direct investment dataset (2011–2026).